Skip to main content

Analytik Jena Takes 20 Percent Stake in Westburg

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Analytik Jena has acquired 20 percent of the shares of its Dutch distribution partner, Westburg, for €150,000 ($215,272).

Based in Leusden, The Netherlands, Westburg specializes in molecular diagnostics sales and distribution. Its primary markets are the Benelux and Scandinavian countries.

"We want our market share in the life sciences in Europe [to] continue to expand and are looking for growth opportunities in targeted regions," Analytik Jena CEO Klaus Berka said in a statement.

Analytik Jena is based in Jena, Germany, and sells bioanalytical instruments and kits. It said that for the current financial year it expects revenues from its products sold by Westburg to be around €400,000.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.